Drug Shortage Report for LUXIQ
| Report ID | 57606 |
| Drug Identification Number | 02366924 |
| Brand name | LUXIQ |
| Common or Proper name | Betamethasone Valerate |
| Company Name | MAYNE PHARMA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BETAMETHASONE VALERATE |
| Strength(s) | 0.12% |
| Dosage form(s) | AEROSOL, FOAM |
| Route of administration | TOPICAL |
| Packaging size | 12g and 100 g |
| ATC code | D07AC |
| ATC description | CORTICOSTEROIDS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-09-30 |
| Actual start date | 2018-08-03 |
| Estimated end date | 2019-02-28 |
| Actual end date | 2018-08-03 |
| Shortage status | Resolved |
| Updated date | 2021-08-13 |
| Company comments | The product is discontinued for business reasons, namely Mayne was unable to identify a Canadian distributor. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1240 SUGG PARKWAY GREENVILLE, NORTH CAROLINA UNITED STATES 27834 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-08-13 | French | Compare |
| v3 | 2021-08-13 | English | Compare |
| v2 | 2018-08-07 | French | Compare |
| v1 | 2018-08-07 | English | Compare |
Showing 1 to 4 of 4